Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis

@article{Moreau2003ClinicalEO,
  title={Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis},
  author={Maxim Moreau and Jacques Dupuis and Norbert H Bonneau and Monique Desiree Desnoyers},
  journal={Veterinary Record},
  year={2003},
  volume={152},
  pages={323 - 329}
}
The efficacy, tolerance and ease of administration of a nutraceutical, carprofen or meloxicam were evaluated in a prospective, double-blind study on 71 dogs with osteoarthritis. [...] Key Method The client-owned dogs were randomly assigned to one of the three treatments or to a placebo control group. The influence of osteoarthritis on the dogs' gait was described by comparing the ground reaction forces of the arthritic dogs and 10 normal dogs.Expand
Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial.
TLDR
Once daily administration of robenacoxib tablets had noninferior efficacy and tolerability compared to carprofen for the treatment of the clinical signs of osteoarthritis in dogs. Expand
Effects of oral administration of meloxicam, carprofen, and a nutraceutical on thyroid function in dogs with osteoarthritis.
TLDR
The administration of meloxicam, carprofen, and CS-G-M did not affect canine thyroid function evaluation and none of these values were within the hypothyroid range. Expand
In dogs diagnosed with osteoarthritis, is meloxicam superior to carprofen for reducing patient discomfort?
TLDR
Both meloxicam and carprofen are validated as effective treatments for canine osteoarthritis but it cannot be suggested thatMeloxicam is superior to carprofe as the available evidence is weak. Expand
Efficacy and safety of the long-term oral administration of carprofen in the treatment of osteoarthritis in dogs
TLDR
The results show that carprofen at 4 mg/kg once daily can be safely used over a 4 month period in the treatment of osteoarthritis in dogs and provides a steadily increasing improvement of the clinical signs. Expand
Effectiveness of disease modifying osteoarthritis agents and carprofen for treatment of canine osteoarthritis
TLDR
The preliminary results imply the clinical benefits of PCSO-524 in combination with carprofen in the treatment of OA, and the greatest improvement was demonstrated in the CPF-PCSO group. Expand
Efficacy of licofelone in dogs with clinical osteoarthritis
TLDR
The dogs' lameness, as assessed by the vas values, had decreased significantly over baseline in both the treated and control groups, and after 28 days the difference had increased. Expand
The effect of doxycycline on canine hip osteoarthritis: design of a 6-months clinical trial
TLDR
DOX had a positive therapeutic effect in dogs with osteoarthritis and biomarker levels of CS-WF6 epitope and hyaluronan were significantly increased and decreased at 2 and 3 months after treatment compared to pretreatment. Expand
Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis.
TLDR
Glu/CS has a positive clinical effect in dogs with osteoarthritis and shows statistically significant improvements in scores for pain, weight-bearing and severity of the condition by day 70 (P<0.001). Expand
Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial.
TLDR
Noninferior efficacy and tolerability of robenacoxib compared with carprofen was demonstrated in dogs with osteoarthritis and was demonstrated for three of six veterinary investigator secondary endpoints and four of six owner efficacy endpoints. Expand
Efficacy and s afety of the long-term oral admi-ni s tration of carprofen in the treatment of o s teo-arthriti s in dog s
The aim of this study conducted in France was to confirm the efficacy and safety of the oral administration of carprofen (Rimadyl®) at 4 mg/kg once a day during four months in the treatment ofExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 45 REFERENCES
Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis.
TLDR
The findings of this investigation suggest that the efficacy, tolerance, and formulation of meloxicam oral suspension make it well suited for the treatment of chronic osteoarthritis in the dog. Expand
Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs.
TLDR
Kinetic gait data provided an objective measurement of lameness in an experimentally induced arthritis model and quantified lameness improvements in response to medication with a nonsteroidal anti-inflammatory drug. Expand
Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs.
TLDR
The study indicates that etodolac is well tolerated by dogs, with minimal adverse effects during an 8-day treatment period, and improvement in force transmission was dosage dependent for the primary outcome measurement (vertical impulse). Expand
Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs.
TLDR
The dogs receiving gelatin or carprofen showed the fewest and the least severe lesions, although there was no statistically significant difference between the three test drugs and the control group (P < or = 0.05). Expand
Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.
TLDR
Under therapeutic conditions, treatment with carprofen could reduce the progression of early structural changes in experimental OA and also delays and/or prevents the abnormal metabolism of subchondral osteoblasts in this model. Expand
The Therapeutic Efficacy of Carprofen (Rimadyl-V™) in 209 Clinical Cases of Canine Degenerative Joint Disease
TLDR
This study concluded that carprofen is an effective NSAID in relieving the clinical signs of DSD in dogs. Expand
Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study.
TLDR
The combination therapy relieves symptoms of knee osteoarthritis and appears safe in this setting and a larger data set is needed to determine the value of this therapy for spinal DJD. Expand
Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage
TLDR
The data obtained in short‐term in vitro cultures indicate that, at the concentrations found in synovial fluid, aceclofenac and meloxicam may exert a favourable effect on the overall metabolism of proteoglycans and HA in cartilage with MOA and SOA. Expand
Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulfate.
TLDR
Analysis of results of this study suggest that prior treatment with GlAm-CS for 21 days had a protective effect against chemically induced synovitis and associated bone remodeling and reduced lameness in dogs with inducedsynovitis. Expand
Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis.
TLDR
The studied combination of glucosamine HCl, sodium chondroitin sulfate and manganese ascorbate was found to be effective for the treatment of radiographically mild to moderate OA of the knee as measured by the ISK. Expand
...
1
2
3
4
5
...